- Filed
- Apr 30, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 24, 2025 | 54.86M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $504.2M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $407.68M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $10.35M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $9.2M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $87.55M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $46.27M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $111.99M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $114.57M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $134.46M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $94.52M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.83B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.74B |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 50.52M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $70.05M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $15.16M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $871.64M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $652.67M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | $4.25 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $4.25 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $27.98M |
| Net Income | Q1 2025 · Mar 31, 2024 | $214.7M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$2.78M |
| Revenue | Q1 2025 · Mar 31, 2024 | $69.25M |